Cleo Diagnostics (ASX:COV) Other Stockholders Equity : A$-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Other Stockholders Equity?

Cleo Diagnostics's Other Stockholders Equity for the quarter that ended in Dec. 2023 was A$-0.00 Mil.

Cleo Diagnostics's quarterly Other Stockholders Equity increased from Dec. 2022 (A$-0.00 Mil) to Jun. 2023 (A$0.00 Mil) but then declined from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$-0.00 Mil).

Cleo Diagnostics Other Stockholders Equity Historical Data

The historical data trend for Cleo Diagnostics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Other Stockholders Equity Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Other Stockholders Equity

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Other Stockholders Equity	-	-	-

Cleo Diagnostics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Cleo Diagnostics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines